Keyword Search
PRESS RELEASE
Aug 14, 2026
Lantheus Announces FDA Approval of TAUKLARIFY™ (Florquinitau F 18 Injection), an F18-Labeled Tau PET Imaging Agent for Alzheimer’s Disease
PRESS RELEASE
Jul 23, 2026
Lantheus to Host Second Quarter 2026 Earnings Conference Call and Webcast on August 6, 2026, at 8:00 a.m. Eastern Time
PRESS RELEASE
Jun 26, 2026
Lantheus Receives Complete Response Letter from FDA for LNTH-2501 (Ga 68 edotreotide)
PRESS RELEASE
Jun 03, 2026
Lantheus to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
PRESS RELEASE
Jun 02, 2026
Lantheus' LNTH-2513 (18F-GP1) PET/CT Awarded SNMMI’s Image of the Year
PRESS RELEASE
May 27, 2026
Lantheus to Present at the William Blair 46th Annual Growth Stock Conference
PRESS RELEASE
May 21, 2026